SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mineralys Therapeutics, Inc. - MLYSAccesswire • Thursday
MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm!PRNewsWire • Thursday
Mineralys Therapeutics, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Shareholders To Take PartAccesswire • Thursday
Bronstein, Gewirtz & Grossman, LLC Encourages Mineralys Therapeutics, Inc. (MLYS) Stockholders to Inquire about Securities InvestigationAccesswire • Thursday
Investors Are Invited By The Schall Law Firm To Join An Inquiry Into Mineralys Therapeutics Inc For Securities Law ViolationsAccesswire • Wednesday
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Mineralys Therapeutics, Inc. (MLYS) and Encourages Investors to Learn More About the InvestigationAccesswire • Wednesday
The Schall Law Firm Is Looking Into Mineralys Therapeutics, Inc. For Possible Securities Fraud And Affected Stockholders Should Reach OutAccesswire • Tuesday
Mineralys Therapeutics, Inc. (MLYS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the InvestigationAccesswire • Tuesday
Mineralys Therapeutics Inc May Have Engaged In Securities Law Violations And The Schall Law Firm Urges Investors With Losses To Partake In An InquiryAccesswire • Monday
Bronstein, Gewirtz & Grossman, LLC Is Investigating Mineralys Therapeutics, Inc. (MLYS) And Encourages Investors to ConnectAccesswire • Monday
The Schall Law Firm Is Looking Into Mineralys Therapeutics, Inc. For Possible Securities Fraud And Affected Shareholders Should Reach OutAccesswire • 09/15/24
Mineralys Therapeutics Inc May Have Committed Securities Law Violations And The Schall Law Firm Invites Investor Participation In An InquiryAccesswire • 09/14/24
The Schall Law Firm Is Looking Into Mineralys Therapeutics, Inc. For Possible Securities Fraud And Stockholders Should Reach OutAccesswire • 09/13/24
Mineralys Therapeutics, Inc. (MLYS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the InvestigationAccesswire • 09/13/24
Mineralys Therapeutics Inc May Have Violated Securities Laws And The Schall Law Firm Invites Investors To Join An InquiryAccesswire • 09/12/24
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Mineralys Therapeutics, Inc.(MLYS) and Encourages Stockholders to Learn More About the InvestigationAccesswire • 09/12/24
The Schall Law Firm Is Looking Into Whether Mineralys Therapeutics, Inc. Committed Securities Fraud And Affected Shareholders Can Reach OutAccesswire • 09/11/24
Bronstein, Gewirtz & Grossman, LLC Encourages Mineralys Therapeutics, Inc.(MLYS) Investors to Inquire about Securities InvestigationAccesswire • 09/11/24
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Mineralys Therapeutics, Inc.(MLYS) And Encourages Investors to Reach OutAccesswire • 09/10/24
MLYS Investors Have Opportunity to Join Mineralys Therapeutics, Inc. Fraud Investigation with the Schall Law FirmGlobeNewsWire • 09/09/24
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Mineralys Therapeutics, Inc.(MLYS) And Encourages Stockholders to Reach OutAccesswire • 09/09/24
Mineralys Therapeutics Inc May Have Violated Securities Laws And Shareholders Are Invited To Help The Schall Law Firm's InquiryAccesswire • 09/09/24
Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D.GlobeNewsWire • 06/14/24